Tag: PCR London Valves 2025
“Durable” valve performance seen with early generation transapical TMVR system
Five-year results of ...
Largest dataset from ALIGN-AR trial shows favourable outcomes with Trilogy valve
Data from 700 patient...
Vascular complications uncommon in study of latest-generation arterial closure device
No major vascular com...
PCR London Valves 2025 hears latest data from LANDMARK trial of Myval TAVI device
Meril Life Sciences h...
Cost analysis suggests benefit of early TAVI in asymptomatic aortic stenosis
Edwards Lifesciences ...
Low rates of PPM seen following TAVI in small aortic annuli with DurAVR system
Thirty-day clinical o...
